Clinical Trial Update: IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System [NA]

View source ↗

Summary

First-in-human study of the IoNIR Ridaforolimus-Eluting Coronary Stent System by Medinol Ltd; the trial is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Coronary Stenosis
• Non-st-elevation Myocardial Infarction

Drugs mentioned

• Ridaforolimus (ridaforolimus)

Snippet

Sponsor: Medinol Ltd. | Conditions: Coronary Stenosis, Coronary Disease | NA | Status: ACTIVE_NOT_RECRUITING